Literature DB >> 23458384

Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national cancer registry data.

John K Dunbar1, John Dillon, O James Garden, David H Brewster.   

Abstract

OBJECTIVES: This study describes changes in the survival of patients with hepatocellular carcinoma (HCC) registered with the Scottish Cancer Registry between 1985 and 2008.
METHODS: Data on patients diagnosed with HCC were extracted from the Scottish Cancer Registry, along with linked data on treatment and risk factors for liver disease. One-, 3- and 5-year relative survival rates were calculated for each time period and a Cox regression model was used to assess the impact of prior admissions on survival.
RESULTS: The incidence of HCC increased between 1985 and 2008. The proportion of patients with prior alcohol-related admissions rose over the time period studied from 16.0% to 27.1%. Five-year relative survival increased in women between 1985-1989 and 2005-2007 from 0.5% [95% confidence interval (CI) 0.0-3.7] to 10.6% (95% CI 5.2-18.1). In men, 5-year relative survival increased from 0.4% (95% CI 0.2-2.2) to 4.4% (95% CI 1.5-9.9). Regression analysis showed that older age, history of alcohol-related admissions and deprivation were associated with lower survival, and hospitalization for viral hepatitis was associated with higher survival.
CONCLUSIONS: Against the background of an increasing incidence of HCC in Scotland, survival times have increased substantially.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 23458384      PMCID: PMC3608982          DOI: 10.1111/j.1477-2574.2012.00567.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  11 in total

1.  Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance.

Authors:  Angelo Sangiovanni; Ersilio Del Ninno; Pierangelo Fasani; Cristina De Fazio; Guido Ronchi; Raffaella Romeo; Alberto Morabito; Roberto De Franchis; Massimo Colombo
Journal:  Gastroenterology       Date:  2004-04       Impact factor: 22.682

2.  Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement.

Authors:  Roderich E Schwarz; Ghassan K Abou-Alfa; Jeffrey F Geschwind; Sunil Krishnan; Riad Salem; Alan P Venook
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

Review 3.  Surgical treatment of hepatocellular carcinoma: expert consensus statement.

Authors:  William Jarnagin; William C Chapman; Steven Curley; Michael D'Angelica; Charles Rosen; Elijah Dixon; David Nagorney
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

4.  The outcome of the first 165 orthotopic liver transplants in Scotland.

Authors:  A J Bathgate; O J Garden; J R Forsythe; K K Madhaven; N D Finlayson; K J Simpson; P C Hayes; A J MacGilchrist
Journal:  Scott Med J       Date:  1999-02       Impact factor: 0.729

5.  Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. EUROCARE Working Group.

Authors:  J Faivre; D Forman; J Estève; M Obradovic; M Sant
Journal:  Eur J Cancer       Date:  1998-12       Impact factor: 9.162

6.  Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

Authors:  John P Duffy; Andrew Vardanian; Elizabeth Benjamin; Melissa Watson; Douglas G Farmer; Rafik M Ghobrial; Gerald Lipshutz; Hasan Yersiz; David S K Lu; Charles Lassman; Myron J Tong; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

Review 7.  Diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hashem B El-Serag; Jorge A Marrero; Lenhard Rudolph; K Rajender Reddy
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

8.  Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001.

Authors:  J West; H Wood; R F A Logan; M Quinn; G P Aithal
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

9.  A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland.

Authors:  S A McDonald; S J Hutchinson; S M Bird; C Robertson; P R Mills; J F Dillon; D J Goldberg
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

10.  Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study.

Authors:  R W Parks; V Bettschart; S Frame; D L Stockton; D H Brewster; O J Garden
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

View more
  3 in total

Review 1.  Effects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host Survival.

Authors:  Gary G Meadows; Hui Zhang
Journal:  Alcohol Res       Date:  2015

2.  The Korea Cancer Big Data Platform (K-CBP) for Cancer Research.

Authors:  Hyo Soung Cha; Jip Min Jung; Seob Yoon Shin; Young Mi Jang; Phillip Park; Jae Wook Lee; Seung Hyun Chung; Kui Son Choi
Journal:  Int J Environ Res Public Health       Date:  2019-06-28       Impact factor: 3.390

3.  Effect of menopausal status on the survival and recurrence of sex-classified hepatocellular carcinoma after liver resection: a case-matched study with propensity score matching.

Authors:  Wenli Zhang; Fuchen Liu; Jian Huang; Xinggang Guo; Wei Dong; Shuxun Wei; Li Li; Xiuli Zhu; Weiping Zhou; Hui Liu
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.